Contact Us

The Definitive Guide to INTERNATIONAL LONGEVITY CENTER ANNUAL REPORT

We make no guarantees about precision of industrial classification. Update  pulmonary infection therapy  are including and upgrading information about numerous thousands of companies every day, and occasionally add companies to the queue for being updated. You can ask for a business to be contributed to the front of the queue for updating, especially beneficial if the address, directors, or other crucial info has actually altered.

Press release material from ACCESSWIRE. The AP news staff was not associated with its development. DALLAS, TX/ ACCESSWIRE/ February 6, 2020/ Enzolytics- (OTC Pink Sheet-ENZC) was alerted by FINRA that an unauthorized news release titled, "Enzolytics Inc., Launches Coronavirus Prevention Set" was dispersed to the public. Enzolytics and its management had no knowledge of this news release in any way, and disavows any info contained in this press release.

Enzolytics, Inc., Inc. is diligently working to bring its filings present and continue with its initiatives for the commercialization of its proprietary proteins for the treatment of HIV.Enzolytics flagship substance ITV-1 (Immune Restorative Vaccine-1) is a suspension of Inactivated Pepsin Portion (IPF), which studies have shown is effective in the treatment of HIV/AIDS.

Rosetta LifeCare - VC - RO - LinkedIn

About - Rosetta

ITV-1 has been shown to regulate the body immune system. ITV-1 has actually likewise been revealed to have anti-viral efficacy. Enzolytics continues to work with its Bulgarian partner, Immunotech Laboratories, BG, to complete the validation of the production process to send the final documents to the Bulgarian drug firm in order to get registration.

Top Guidelines Of розета лайфкеър българия оод - Papagal.bg

is a drug advancement business dedicated to the commercialization of its proprietary proteins for the treatment of HIV/AIDS. Enzolytics is dedicated to producing drugs for the much better health of humanity, Safe Harbor Declaration: This press release consists of forward-looking declarations that involve dangers and uncertainties connected with monetary projections, spending plans, turning point timelines, medical development, regulatory approvals, and other risks explained by Enzolytics, Inc.